Common Diabetes Meds Tied to Serious COVID-19 Complication

TUESDAY, Jan. 12, 2021 — Diabetics who’ve contracted COVID-19 should suspend their use of a class of common diabetes drugs known as sodium-glucose co-transporter 2 inhibitors (SGLT2i), new research warns.
People using these medications for diabetes…
Source: Topamax